Skip to main content
. 2020 Apr 6;4(7):1311–1320. doi: 10.1182/bloodadvances.2019001267

Table 4.

Cox multivariate analysis for OS

OS HR 95% CI P FDR-adjusted P
Treatment group
 HMA vs IC 1.68 0.95-2.98 .076 .076
 HMA + VEN vs IC 0.31 0.12-0.83 .019 .038
ELN risk group
 Intermediate vs favorable 1.18 0.59-2.36 .635
 Adverse vs favorable 1.30 0.80-2.13 .293
Age at diagnosis, y 1.04 1.02-1.06 <.0001
Secondary AML 1.37 0.76-2.48 .302
ECOG performance status
  ≥2 vs <2 1.79 1.16-2.76 .009
FLT3-ITD
 Positive vs negative 1.55 1.09- 2.21 .016

FDR, false discovery rate.